Inflammation Markers in Adipose Tissue and Cardiovascular Risk Reduction by Pomegranate Juice in Obesity Induced by a Hypercaloric Diet in Wistar Rats
Authors:
- Maria Monica Michicotl-MenesesMMMaria Monica Michicotl-Meneses
- María del Rocío Thompson-BonillaMTMaría del Rocío Thompson-Bonilla
- César A. Reyes-LópezCRCésar A. Reyes-López
- Blanca Estela García-PérezBlanca Estela García-Pérez
- Itzel I. López-TenorioILItzel I. López-Tenorio
- Cynthia Ordaz-PichardoCOCynthia Ordaz-Pichardo
- María Eugenia Jaramillo-FloresMJMaría Eugenia Jaramillo-Flores
Open Access
Abstract
Pomegranate juice (Punica granatum) has been used since ancient times in traditional medicine (Unani Medicine, Ayurveda); its main compounds are anthocyanins and ellagic acid, which have anti-inflammatory, antioxidant, hepatoprotective, and cardiovascular health effects. The objective was to evaluate the effect of pomegranate juice on inflammation, blood pressure, and vascular and physiological markers associated with obesity induced by a high-fat diet in a murine model. The results show that pomegranate juice reduces the concentration of low-density lipoprotein cholesterol (cLDL) 39% and increases the concentration of high-density lipoprotein cholesterol (cHDL) by 27%, leading to a 12%–18% decrease in the risk of cardiovascular diseases (CVD). In addition to reducing blood pressure by 24%, it also had an antiatherogenic effect by decreasing sE-selectin levels by 42%. On the other hand, the juice significantly increased adiponectin levels in adipose tissue, decreased levels of inflammation markers (tumor necrosis factor-α (TNF-α), plasminogen activator inhibitor-1 (PAI-1), interleukin-17A (IL-17A), interleukin-6 (IL-6), interleukin-1β (IL-1β)), and inhibited the monocyte chemoattractant protein-1 (MCP-1). Pomegranate juice requires clinical studies to prove its immunoregulatory and therapeutic effects on cardiovascular and atherogenic risks.Keywords
This publication has 78 references indexed in Scilit:
- Modulation of miRNA Expression by Dietary Polyphenols in apoE Deficient Mice: A New Mechanism of the Action of PolyphenolsPLOS ONE, 2012
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Inflammation, a Link between Obesity and Cardiovascular DiseaseMediators of Inflammation, 2010
- Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A ReviewMediators of Inflammation, 2010
- Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitroCytokine, 2009
- TNF‐α and adipocyte biologyFEBS Letters, 2007
- Inflammation, obesity and comorbidities: the role of dietPublic Health Nutrition, 2007
- Effects of a Pomegranate Fruit Extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesisCardiovascular Research, 2007
- Characterization and Measurement of Anthocyanins by UV‐Visible SpectroscopyCurrent Protocols in Food Analytical Chemistry, 2001
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998